Scoliosis: A Natural-Health and Nutritional Reference
1. Definition and Clinical Presentation
Scoliosis is defined as a deviation of the normal vertical line of the spine, consisting of a lateral curvature with rotation of the vertebrae within the curve. Typically, for scoliosis to be considered, there should be at least 10° of spinal angulation on the posterior-anterior radiograph associated with vertebral rotation. It is recognized as a complex three-dimensional deformity, meaning it involves not only side-to-side bending but also axial rotation of the vertebral bodies.
The condition was first described in detail by Hippocrates and takes its name from the Greek word scolios, meaning "crooked"; it consists of the lateral displacement of the spine and is almost always associated with rotation of the vertebral bodies. Depending on which region of the spine is affected, scoliosis is classified as "thoracic," "lumbar," or "thoracolumbar."
Scoliosis is usually diagnosed clinically. The typical screening consists of the "Adam's test," in which a curve and a convex posterior wall prominence ("rib hump") are noted on the back when the patient bends forward.
Types and Classification
The causes of scoliosis vary and are classified broadly as congenital, neuromuscular, syndrome-related, idiopathic, and spinal curvature due to secondary reasons. Congenital scoliosis is due to a vertebral abnormality causing the mechanical deviation of the normal spinal alignment.
Adolescent idiopathic scoliosis (AIS) is a three-dimensional spine deformity that takes place at early ages around 11 to 18 years, and is the most common type of idiopathic scoliosis in children. Scoliosis can also be classified into early- and late-onset scoliosis, with the dividing line at age 5. Adult scoliosis, by definition, affects patients aged 18 or older.
Type I adult (degenerative) scoliosis is the primary degenerative or de novo scoliosis which develops after skeletal maturity and is characterized by minimal structural vertebral deformities, advanced degenerative changes, and a predominance of lower lumbar curves. It results from asymmetric degeneration of disc and facet joints, and osteoporotic compression fractures. Type II scoliosis is the progressive idiopathic deformity that develops before skeletal maturity but becomes symptomatic in adult life. It does not confine itself to the lumbar spine alone; it can involve the cervical and thoracic spine as well.
2. Body Systems Involved
Musculoskeletal System
The musculoskeletal system is the most directly and prominently involved. Paravertebral muscle (PVM) is considered a contributing factor of idiopathic scoliosis; collagen is crucial for maintaining the mechanical properties of PVM. Collagen content is decreased in the scoliotic intervertebral disc (IVD), disrupting the structural integrity of the spinal motion segment. Diseases of the intervertebral disc, including scoliosis, are characterized by changes in the extracellular matrix components that affect the mechanical function of the tissue. The stability of the collagenous components and hence the mechanical integrity of connective tissues such as the disc is dependent on the degree and type of cross-links between the collagen molecules.
The glycosaminoglycans of the nucleus pulposus are decreased in patients with idiopathic scoliosis; loss of proteoglycans may affect the viscoelastic properties of the intervertebral discs, which may result in permanent deformation.
Respiratory System
Idiopathic scoliosis, a common disorder of lateral displacement and rotation of vertebral bodies during periods of rapid somatic growth, has many effects on respiratory function. Scoliosis results in a restrictive lung disease with a multifactorial decrease in lung volumes, displaces the intrathoracic organs, impedes the movement of ribs, and affects the mechanics of the respiratory muscles. Scoliosis decreases the chest wall as well as the lung compliance and results in increased work of breathing at rest, during exercise, and sleep. Pulmonary hypertension and respiratory failure may develop in severe disease.
Respiratory system abnormalities are detected in 60–75% of patients with severe scoliosis, while clinical manifestations of cardiorespiratory dysfunction occur in 30–40% of affected adolescents.
Cardiovascular System
Involvement of the thoracic spine (alone or in combination with the lumbar spine) is primarily responsible for the respiratory and cardiovascular complications of scoliosis. This altered cardiac strain may be explained by the deformity of the thoracic cage in scoliosis limiting cardiac diastolic movement. The mechanical abnormalities of the thoracic spine as well as the impact on the pulmonary system may be the primary cause of the heart involvement. Secondary involvement via altered pulmonary haemodynamics may be possible, where spinal curvature impacts pulmonary pressures leading to pulmonary hypertension. Direct compression of the myocardium could occur in conjunction with pulmonary involvement.
A UK Biobank study was the first to investigate an interplay between scoliosis and cardiac manifestations in a large adult population. The study identified an increased lifetime risk of major adverse cardiovascular events, driven by heart failure and atrial fibrillation, and altered radial and longitudinal peak diastolic strain rates in participants with scoliosis.
Skeletal and Bone Metabolism
Generalized osteopenia and spinal deformity occur concomitantly in adolescent idiopathic scoliosis (AIS) during the peripubertal period. Multivariate analysis has indicated that Cobb angle was inversely and independently associated with axial and peripheral bone mineral density (BMD) and bone mineral content (BMC). Curve severity was an inverse and independent associated factor on bone mineral mass of AIS during peripuberty. Of AIS patients with low preoperative BMD, 62.5% still had low BMD after reaching bone maturity, and low BMD was associated with the severity of scoliosis.
Endocrine and Neuroendocrine Systems
AIS usually initiates during puberty, the peak period of human growth when the secretion of numerous hormones is changing, and it is more common in females than in males. Accumulating evidence shows that the abnormal levels of many hormones including estrogen, melatonin, growth hormone, leptin, adiponectin, and ghrelin may be related to the occurrence and development of AIS.
Connective Tissue
Scoliosis is a clinical feature of inherited connective-tissue disorders, including Marfan syndrome. Mutations within the gene of FBN1 (fibrillin), a component of the extracellular matrix, are linked to Marfan syndrome and similar clinical phenotypes. Secondary causes of scoliosis are grouped into three categories: inherited disorders of connective tissue, neurologic disorders, and musculoskeletal disorders.
Psychosocial Impact
Young adolescents, as well as their peers and parents, often visualize scoliosis as a body disfigurement, which can lead to negative body image perceptions. This dissatisfaction with appearance can often lead to decreased self-esteem, anxiety, and even depression.
3. Epidemiology
In population studies, 1–3% of children between 10 and 16 present some spinal curvature, but the vast majority of subjects with a spinal curve will never require surgery. Scoliosis is more commonly found in women than men (approximately 2.5:1), which agrees with previous scoliosis case cohort studies.
Risk factors for progression include female gender, curve magnitude of greater than 50° at maturity, curve type, and remaining growth. Curves progress most rapidly when the child is growing rapidly — during the adolescent growth spurt.
4. Contributing and Associated Factors
Genetic and Hereditary Factors
The etiology of scoliosis appears to be multifactorial, with a genetic tendency to the deformity that is triggered in different individuals by different factors — some medical, some mechanical, and some genetic. While the hereditary and genetic origin of scoliosis appears unassailable and several chromosomes are known to be involved in transmission, the role assumed by each individual chromosome remains uncertain, and the mechanisms leading to the expression of scoliosis have yet to be determined.
A more apparent risk factor for scoliosis is family history. In 2012, Grauers et al. estimated that the heritability of scoliosis is about 38%, using data from the Swedish Twin Registry.
For idiopathic scoliosis, genetic factors are categorized into three groups: genes associated with susceptibility, disease progression, and both.
Hormonal Factors
Scoliosis develops at the quickest rate during the child's growth spurt, which prompted research on the role of the growth hormone in scoliosis aetiology. Melatonin is another hormone studied as a possible factor involved in the development of this condition.
A link between melatonin and AIS was first reported in 1959 by Thillard et al., who found that the removal of the pineal gland in chickens induced a spinal deformity similar to scoliosis. The concentration and rhythm of melatonin secretion can play an important role by influencing the pathogenesis of adolescent idiopathic scoliosis.
As one of the sex hormones, estrogen has numerous functions; lack of estrogen leads to deficits of bone maturation which can further participate in AIS development. The response of cells to estrogen in AIS patients was found to be altered, and this might result in the delay of menarche and osteopenia, which disturbed the maturation of bone.
The autonomic nervous system, through its hypothalamic neuroendocrine control of puberty, skeletal growth, and menarche, contributes importantly to the pathogenesis of adolescent idiopathic scoliosis.
Leptin and Body Composition
Low BMI has been found to be associated with AIS, as well as abnormal levels of leptin — a hormone known to play a role in fat regulation and the onset of puberty. Lower body mass index (BMI) in girls with AIS is associated with decreased circulating leptin levels. Leptin receptors in AIS mesenchymal stem cells were also found to be down-regulated, which might result in hyposensitivity to circulating leptin.
Neuromuscular Factors
Neuromuscular etiologies, such as cerebral palsy, spinal amyotrophy, or myelodysplasia, are all neurologic disorders that in themselves can lead to scoliosis. Dysfunctions of the nervous system are recognized risks related to the development of scoliosis, and are classified as belonging to a separate aetiological category.
Biomechanical and Growth-Related Factors
Progressive scoliosis increases linearly, and the rate of increase accelerates at puberty. The sagittal plane of AIS is associated with hypokyphosis. A relatively small imbalance of growth of anterior and posterior structures has been postulated as a cause; according to this hypothesis, the anterior structures grow more rapidly than the posterior ones, and with bending forward, the vertebral bodies at the apex tend to move out of the way by rotating to the side.
Environmental and Fetal Factors
There has been some linkage of vertebral malformations with the consumption of alcohol, maternal insulin-dependent diabetes mellitus, and anticonvulsant medications such as valproic acid and dilantin during fetal development.
5. Bone Mineral Density and Nutritional Status in Scoliosis
Approximately 30% of women with AIS suffer from systemic osteopenia, which strongly contributes to the progression of spinal curvature in adolescent females following skeletal maturity. There is a trend that the BMD of children with idiopathic scoliosis is significantly lower than that of healthy individuals. The prevalence of osteoporosis in children with IS was much higher than in healthy controls, suggesting that osteoporosis may be a comorbidity in IS patients involved in the onset or progress of IS.
Research evidence supports a complex system model which demonstrates that scoliosis and low BMD share common genetic, hormonal, nutritional, and mechanical factors that affect spinal structure and complete skeletal health.
Some studies have shown that patients with adolescent idiopathic scoliosis have different anthropometric features compared with their peers, such as taller stature, lower body mass index, and lower bone mineral density. Yet the causes explaining these differences remain uncertain. Nutritional intake and status, combined with physical activity, could explain these discrepancies.
6. Nutrients, Herbs, and Natural Ingredients: Traditional Use and Scientific Evidence
Note: This section strictly distinguishes traditional-use claims (historical, ethnobotanical, or empirical practice) from peer-reviewed scientific evidence. For scoliosis specifically, most nutritional research focuses on AIS, and no traditional herbal or botanical monograph system (German Commission E, WHO Monographs, ESCOP) has issued specific monographs for scoliosis. Herbs mentioned below are those studied in the context of musculoskeletal or bone-health mechanisms relevant to scoliosis or discussed in published literature.
Vitamin D
Scientific Evidence:
Regarding nutritional status, it was found that AIS patients have lower vitamin D levels than controls and that most patients have insufficient or deficient vitamin D serum levels.
A 2023 meta-analysis of eight comparative studies found that demographic characteristics, bone density, serum levels of vitamin D, parathyroid hormone, and phosphate levels were not significantly different between the AIS group and controls when assessed as group means, indicating population-level heterogeneity. However, other authors have demonstrated that the level of 25-hydroxyvitamin D was lower in patients with idiopathic scoliosis compared with a healthy group of patients.
One randomized, double-blinded placebo-controlled trial enrolled 330 patients randomized into three groups of 110. The low-dose vitamin D group received 600 mg calcium with vitamin D 400 IU daily; the high-dose vitamin D group received 600 mg calcium with vitamin D 800 IU daily; and the placebo group received placebo tablets daily. At baseline and 2 years after treatment, investigators evaluated the patients' Cobb angle and tested spinal bone mineral density with dual-energy X-ray absorptiometry. The results provided evidence of an improvement of bone health in AIS patients using the supplementation, in terms of bone density and bone quality.
Further studies are required to elucidate the possible role of vitamin D in the pathogenesis and clinical management of AIS. Overall evidence for vitamin D's role in scoliosis initiation or curve progression is preliminary and mixed; current research supports its importance for bone health in AIS patients but does not establish it as a direct cause or cure of scoliosis.
Calcium
Scientific Evidence:
Generalized low bone mass of girls with adolescent idiopathic scoliosis is related to inadequate calcium intake and weight-bearing physical activity in the peripubertal period. Among scoliosis patients, those with osteopenia had more severe scoliosis in adulthood than those without. These findings suggest a need for osteopenia screening and prevention in children with scoliosis, including monitoring of physical activity and calcium intake during bracing.
One clinical study found that serum calcium level remained constant even after one year of supplementation with 600 mg of calcium per day, suggesting no measurable impact on serum calcium per se. However, the authors held that calcium should be taken along with vitamin D due to the transporter mechanism of vitamin D, which brings calcium to bones, thus increasing bone density.
Studies describing energy or nutrient intake in AIS mostly focused on total energy and calcium and found no difference in intake between AIS and control cohorts. Evidence for calcium supplementation specifically preventing curve progression in AIS is currently limited and inconclusive; its importance lies primarily in the prevention and management of co-occurring osteopenia.
Melatonin
Traditional Use: Melatonin is not a traditionally-used herbal remedy in the historical or ethnobotanical sense. Its supplemental use in scoliosis has emerged from modern endocrinological research rather than traditional medicine systems.
Scientific Evidence:
Melatonin (MT) is an indoleamine present in almost all animals and participates in the regulation of biological rhythms. In addition to regulating biological rhythms, melatonin also participates in biological processes including bone development. Research has found that the expression of melatonin receptors in AIS mesenchymal stem cells was down-regulated, which may reduce response to melatonin treatment, since melatonin increases alkaline phosphatase activity and glycosaminoglycan synthesis and other differentiation-related gene expression; a lack of response to melatonin might alter this process and then influence membranous and endochondral ossification.
One randomized, case–control, interventional clinical trial monitored the progression of idiopathic scoliosis curvature following the administration of melatonin 1.5 mg/daily, calcium 600 mg/daily, and vitamin D 2000 IU/daily. Evidence linking melatonin supplementation to measurable scoliosis outcomes remains preliminary; the overall body of published clinical evidence is small.
Magnesium
Scientific Evidence:
The combination of nutritional deficiencies that affect calcium, magnesium, zinc, and vitamin K2 levels in patients leads to increased metabolic risk in the context of scoliosis and low bone mineral density. Magnesium is a required cofactor for bone mineralization and neuromuscular function. No large-scale clinical trials have evaluated magnesium supplementation specifically for scoliosis management. Evidence in this context is indirect and extrapolated from general bone metabolism research.
Vitamin K
Scientific Evidence:
Nutritional deficiencies affecting calcium, magnesium, zinc, and vitamin K2 levels lead to increased metabolic risk in individuals with scoliosis and low BMD. Vitamin K2 (menaquinone) is known in general bone metabolism research to support osteocalcin carboxylation and bone matrix formation, but no scoliosis-specific clinical trials examining vitamin K2 in isolation have been identified in the peer-reviewed literature. Evidence for its specific role in scoliosis is therefore indirect and extrapolated.
Zinc
Scientific Evidence:
Nutritional deficiencies that affect calcium, magnesium, zinc, and vitamin K2 levels in patients lead to increased metabolic risk relevant to scoliosis and bone health. Zinc is an essential cofactor for collagen synthesis and bone formation enzymes. No scoliosis-specific clinical trials on zinc supplementation have been identified in peer-reviewed literature; the evidence is indirect.
Collagen (Structural Considerations)
Scientific Evidence:
Scoliosis resulted in a significant decrease in collagen content in the intervertebral disc in a systematic review and meta-analysis of connective tissue extracellular matrix composition. The stability of the collagenous components and hence the mechanical integrity of connective tissues such as the disc is dependent on the degree and type of cross-links between the collagen molecules. Changes in the distribution of cross-links occur with age, degenerative disc disease, and scoliosis. Oral collagen supplementation has not been studied in randomized trials specifically focused on scoliosis; the significance of these structural findings for dietary collagen intake in scoliosis remains unknown.
Omega-3 Fatty Acids
Traditional Use: Omega-3-rich fish oils and plant seed oils have been used historically in various traditional medical systems to address joint and inflammatory conditions generally, but no traditional medical system has formally categorized their use specifically for spinal deformity.
Scientific Evidence:
No peer-reviewed clinical trials specifically evaluating omega-3 fatty acid supplementation in scoliosis patients were identified in this review. Omega-3 fatty acids possess well-documented anti-inflammatory properties in general musculoskeletal contexts, and chronic low-grade inflammation has been proposed as a mechanism in adult degenerative scoliosis, where adult degenerative scoliosis involves angiogenesis and inflammation, extracellular matrix degradation, neural associations, and hormonal influences. The extrapolation of anti-inflammatory benefits to scoliosis-specific outcomes is speculative at this time, with no direct human trial evidence.
Curcumin (Turmeric)
Traditional Use: Curcumin, the principal bioactive constituent of Curcuma longa (turmeric), has a long history of use in Ayurvedic and traditional Chinese medicine as an anti-inflammatory and analgesic agent for musculoskeletal pain and joint conditions generally. It has not been specifically indicated for spinal curvature in any classical traditional medical texts.
Scientific Evidence:
No peer-reviewed clinical trials were identified in the searched literature that evaluated curcumin supplementation specifically for scoliosis, its progression, or associated structural changes. Any proposed benefit in scoliosis-related inflammation or pain would be extrapolated from curcumin's general anti-inflammatory mechanisms and is not supported by direct clinical evidence in this condition.
Glycosaminoglycans (Including Glucosamine and Chondroitin)
Scientific Evidence:
The glycosaminoglycans of the nucleus pulposus are decreased in patients with idiopathic scoliosis; loss of proteoglycans may affect the viscoelastic properties of the intervertebral discs, which may result in permanent deformation. Melatonin increases glycosaminoglycan synthesis in mesenchymal stem cells, suggesting GAG metabolism is relevant to scoliosis pathophysiology. However, no clinical trials have evaluated exogenous glucosamine or chondroitin supplementation for scoliosis-specific outcomes. The relationship is biochemically plausible but remains unconfirmed by clinical evidence.
7. Dietary and Lifestyle Factors
Dietary Patterns and Nutritional Status
Some studies have shown that patients with adolescent idiopathic scoliosis have different anthropometric features compared with their peers, such as taller stature, lower body mass index, and lower bone mineral density. Yet the causes explaining these differences remain uncertain. Nutritional intake and status, combined with physical activity, could explain these discrepancies.
Studies describing energy or nutrient intake in AIS mostly focused on total energy and calcium, and found no difference in intake between AIS and control cohorts. Regarding nutritional status, it was consistently found that AIS patients have lower vitamin D levels than controls, and that most patients have insufficient or deficient vitamin D serum levels.
Calcium Intake and Bone Loading
Generalized low bone mass of girls with adolescent idiopathic scoliosis is related to inadequate calcium intake and weight-bearing physical activity in the peripubertal period. These findings suggest a need for osteopenia screening and prevention in children with scoliosis, for monitoring physical activity and calcium intake during bracing.
Physical Activity
Physical activity is considered both a treatment and a causative factor for idiopathic scoliosis; however, evidence for a causal relationship between physical activity levels and idiopathic scoliosis in adolescents is conflicting.
A systematic review and meta-analysis including sixteen studies with 9,627 participants found that a history of vigorous physical activity significantly reduced the odds of being newly diagnosed with AIS by 24% (odds ratio 0.76, 95% CI 0.65–0.89), rated as high-certainty evidence.
The combination of reduced physical activity, restricted bracing use, and impaired mechanotransduction leads to decreased skeletal loading, which prevents adolescents from reaching their peak bone mass.
Body Mass Index and Body Composition
One contributing factor to AIS risk is body mass index (BMI). Several studies have linked relatively high BMI with earlier menarche and low BMI with delayed menarche. Interestingly, low BMI has also been found to be associated with AIS, as well as abnormal levels of leptin.
Bracing and Physical Activity Interaction
Bone mineral density values are lower in scoliosis patients than in controls. Among patients, those with osteopenia wore a brace significantly longer and had more severe scoliosis in adulthood than those without osteopenia. This underlines how nutritional status and physical activity cannot be considered in isolation from conventional management approaches.
8. Summary of Evidence Strength
- Vitamin D (deficiency association): Consistently replicated finding across multiple observational studies and one meta-analysis (8 studies); lower serum 25-OH-D in AIS patients is a moderately well-supported association. Causal and therapeutic roles remain under investigation. Evidence: moderate (observational).
- Calcium (bone health in AIS): Cross-sectional and one RCT data support a link between calcium intake, bone density, and AIS severity. Direct effect on curve progression is not confirmed. Evidence: limited to moderate.
- Melatonin (hormonal association): Animal model and cell-biology evidence is substantial; human clinical trial data on supplementation are preliminary and small in scale. Evidence: preliminary (human); moderate (mechanistic/animal).
- Vigorous Physical Activity: High-certainty evidence from a systematic review (16 studies, 9,627 participants) that vigorous physical activity reduces odds of AIS diagnosis. Evidence: moderate to strong (epidemiological).
- Magnesium, Zinc, Vitamin K2: Identified as nutritional factors affecting metabolic risk in scoliosis/low-BMD research. No scoliosis-specific clinical trials. Evidence: indirect/extrapolated.
- Omega-3 fatty acids, Curcumin: Plausible anti-inflammatory rationale in the context of degenerative scoliosis; no scoliosis-specific clinical trials identified. Evidence: theoretical/not established.
- Collagen/Glycosaminoglycans (dietary): Structural deficiencies documented in scoliotic disc tissue; dietary supplementation has not been trialed in scoliosis. Evidence: mechanistic only.
References
Go back